참고문헌 (55)

1. 1 Hui D. S. Zumla A. Advancing priority research on the Middle East respiratory syndrome coronavirus The Journal of Infectious Diseases 2014 209 2 173 176 24218505 

   상세보기

2. 2 Loomis D. Grosse Y. Lauby-Secretan B. The carcinogenicity of outdoor air pollution The Lancet Oncology 2013 14 13 1262 1263 10.1016/S1470-2045(13)70487-X 2-s2.0-84888086414 84888086414 25035875 

   상세보기

3. 3 Head K. A. Jurenka J. S. Inflammatory bowel disease part 1: ulcerative colitis—pathophysiology and conventional and alternative treatment options Alternative Medicine Review 2003 8 3 247 283 12946238 

4. 4 Munkholm P. Langholz E. Hollander D. Intestinal permeability in patients with Crohn’s disease and ulcerative colitis and their first degree relatives Gut 1994 35 1 68 72 10.1136/gut.35.1.68 0028103683 8307453 

   상세보기

5. 5 Truelove S. C. Horler A. R. Richards W. Serial biopsy in ulcerative colitis British Medical Journal 1955 2 4956 1590 1593 13269923 

   상세보기

6. 6 Lix L. M. Graff L. A. Walker J. R. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease Inflammatory Bowel Diseases 2008 14 11 1575 1584 10.1002/ibd.20511 2-s2.0-59249094987 59249094987 18512245 

   상세보기

7. 7 Opheim R. Bernklev T. Fagermoen M. S. Cvancarova M. Moum B. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway Scandinavian Journal of Gastroenterology 2012 47 12 1436 1447 10.3109/00365521.2012.725092 2-s2.0-84869989469 84869989469 23003678 

   상세보기

8. 8 Oxelmark L. Lindberg A. Löfberg R. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study European Journal of Gastroenterology & Hepatology 2016 28 11 1320 1328 10.1097/MEG.0000000000000710 2-s2.0-84990822047 27472271 

   상세보기

9. 9 Rawsthorne P. Clara I. Graff L. A. The Manitoba inflammatory bowel disease cohort study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products Gut 2012 61 4 521 527 10.1136/gutjnl-2011-300219 2-s2.0-84857795827 84857795827 21836028 

   상세보기

10. 10 Weizman A. V. Ahn E. Thanabalan R. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease Alimentary Pharmacology & Therapeutics 2012 35 3 342 349 10.1111/j.1365-2036.2011.04956.x 2-s2.0-84855344258 22176478 

    상세보기

11. 11 Tsiang Y. Li P. T. Asclepiadaceae Delectis Florae Reipublicae Popularis Sinicae Agendae Academiae Sinicae 1977 63 Beijing Science Press 249 575 Flora Reiplicae Popularis Sinicae (in Chinese) 

12. 12 Chang A. Kwak B. Y. Yi K. Kim J. S. The effect of herbal extract (EstroG-100) on pre-, peri- and post-menopausal women: a randomized double-blind, placebo-controlled study Phytotherapy Rresearch 2012 26 4 510 516 

13. 13 Zenk M. H. el-Shagi H. Schulte U. Anthraquinone production by cell suspension cultures of Morinda citrifolia Planta Medica 1975 28 79 101 10.1055/s-0028-1104768 

    상세보기

14. 14 Zhang X. Shan L. Huang H. Rapid identification of acetophenones in two Cynanchum species using liquid chromatography-electrospray ionization tandem mass spectrometry Journal of Pharmaceutical and Biomedical Analysis 2009 49 3 715 725 10.1016/j.jpba.2009.01.009 2-s2.0-61449103478 61449103478 19201126 

    상세보기

15. 15 Korea Food and Drug Administration (KFDA) July 2016, http://www.mfds.go.kr/herbmed/index.do?nMenuCode=7&code=KHP-N126&includeUrl=/herbmed/view.jsp/ 

16. 16 Choi D. H. Lee Y. J. Oh H. C. Improved endothelial dysfunction by Cynanchum wilfordii in apolipoprotein E(−/−) mice fed a high fat/cholesterol diet Journal of Medicinal Food 2012 15 2 169 179 10.1089/jmf.2010.1222 2-s2.0-84863078321 84863078321 22082065 

    원문보기 상세보기

17. 17 Hwang B. Y. Kim S. E. Kim Y. H. Pregnane glycoside multidrug-resistance modulators from Cynanchum wilfordii Journal of Natural Products 1999 62 4 640 643 10.1021/np980479x 2-s2.0-0008869282 0008869282 10217732 

    상세보기

18. 18 Kim H. S. Effects of Cynanchum wilfordii extract on serum lipid components and enzyme activities in hyperlipidemic and streptozotocin-induced diabetic rats Korean Journal of Human Ecology 2004 7 2 1 11 

19. 19 Niu J. Z. Ye B. K. Wang D. F. Observation of the protection effect of Baishouwu to the liver of the high serum cholesterol mouse Ji Sheng Chong Yu Yi Xue kun Chong Xue Bao 1998 3 266 268 

20. 20 Shan L. Liu R. H. Shen Y. H. Gastroprotective effect of a traditional Chinese herbal drug “baishouwu” on experimental gastric lesions in rats Journal of Ethnopharmacology 2006 107 3 389 394 10.1016/j.jep.2006.03.022 2-s2.0-33748418147 33748418147 16678989 

    상세보기

21. 21 Shan L. Zhang W. D. Zhang C. Liu R. H. Su J. Zhou Y. Antitumor activity of crude extract and fractions from root tuber of Cynanchum auriculatum Royle ex Wight Phytotherapy Research 2005 19 3 259 261 10.1002/ptr.1678 2-s2.0-20444497665 20444497665 15934033 

    상세보기

22. 22 Yoon M. Y. Choi N. H. Min B. S. Potent in vivo antifungal activity against powdery mildews of pregnane glycosides from the roots of Cynanchum wilfordii Journal of Agricultural and Food Chemistry 2011 59 22 12210 12216 10.1021/jf2039185 2-s2.0-81255195763 81255195763 21992072 

    상세보기

23. 23 Srivastava R. Kulshreshtha D. K. Bioactive polysaccharides from plants Phytochemistry 1989 28 2877 2883 10.1016/0031-9422(89)80245-6 2-s2.0-0000351080 

    상세보기

24. 24 You L. Gao Q. Feng M. Structural characterisation of polysaccharides from Tricholoma matsutake and their antioxidant and antitumour activities Food Chemistry 2013 138 4 2242 2249 10.1016/j.foodchem.2012.11.140 2-s2.0-84875192307 84875192307 23497882 

    상세보기

25. 25 Jang M. Lim T. G. Ahn S. Immune-enhancing effects of a high molecular weight fraction of Cynanchum wilfordii Hemsley in macrophages and immunosuppressed mice Nutrients 2016 8 10 p. 600 10.3390/nu8100600 2-s2.0-84989361095 

    상세보기

26. 26 Dore C. M. das C Faustino Alves M. G. Will L. S. A sulfated polysaccharide, fucans, isolated from brown algae Sargassum vulgare with anticoagulant, antithrombotic, antioxidant and anti-inflammatory effects Carbohydrate Polymers 2013 vol. 91 1 467 475 10.1016/j.carbpol.2012.07.075 2-s2.0-84867337980 84867337980 23044157 

    상세보기

27. 27 Murthy S. N. Cooper H. S. Shim H. Shah R. S. Ibrahim S. A. Sedergran D. J. Treatment of dextran sulfate sodium induced murine colitis by intracolonic cyclosporine Digestive Diseases and Sciences 1993 38 9 1722 1734 10.1007/BF01303184 2-s2.0-0027275654 0027275654 8359087 

    상세보기

28. 28 Hamamoto N. Maemura K. Hirata I. Murano M. Sasaki S. Katsu K. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)) Clinical and Experimental Immunology 1999 117 3 462 468 10.1046/j.1365-2249.1999.00985.x 2-s2.0-0032793928 0032793928 10469048 

    상세보기

29. 29 Sun J. Zhang X. Broderick M. Fein H. Measurement of nitric oxide production in biological systems by using Griess reaction assay Sensors 2003 3 8 276 284 10.3390/s30800276 

    상세보기

30. 30 Okayasu I. Hatakeyama S. Yamada M. Ohkusa T. Inagaki Y. Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 1990 98 3 694 702 10.1016/0016-5085(90)90290-H 0025181580 1688816 

    상세보기

31. 31 Hendrickson B. A. Gokhale R. Cho J. H. Clinical aspects and pathophysiology of inflammatory bowel disease Clinical Microbiology Reviews 2002 15 1 79 94 10.1128/CMR.15.1.79-94.2002 2-s2.0-0036141470 0036141470 11781268 

    상세보기

32. 32 Kim D. S. Ko J. H. Jeon Y. D. Ixeris dentate NAKAI reduces clinical score and HIF-1 expression in experimental colitis in mice Evidence-based Complementary and Alternative Medicine 2013 2013 67 p. 671281 10.1155/2013/671281 2-s2.0-84885339773 24194783 

    상세보기

33. 33 Kurutas E. B. Cetinkaya A. Bulbuloglu E. Kantarceken B. Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis Mediators of Inflammation 2005 2005 6 390 394 10.1155/MI.2005.390 2-s2.0-29144454969 29144454969 16489261 

    상세보기

34. 34 Egger B. Bajaj-Elliott M. MacDonald T. T. Inglin R. Eysselein V. E. Büchler M. W. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency Digestion 2000 62 4 240 248 10.1159/000007822 0033768784 11070407 

    상세보기

35. 35 Garside P. Cytokines in experimental colitis Clinical and Experimental Immunology 1999 118 3 337 339 10.1046/j.1365-2249.1999.01088.x 2-s2.0-0032694892 0032694892 10594548 

    상세보기

36. 36 Ito R. Shin-Ya M. Kishida T. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice Clinical and Experimental Immunology 2006 146 2 330 338 10.1111/j.1365-2249.2006.03214.x 2-s2.0-33750049009 33750049009 17034586 

    상세보기

37. 37 Taghipour N. Molaei M. Mosaffa N. An experimental model of colitis induced by dextran sulfate sodium from acute progresses to chronicity in C57BL/6: correlation between conditions of mice and the environment Gastroenterology and Hepatology from bed to Bench 2016 9 1 45 52 26744614 

38. 38 Crowe S. E. Perdue M. H. Functional abnormalities in the intestine associated with mucosal mast cell activation Regional Immunology 1992 4 2 113 117 1503888 

39. 39 Cirillo C. Sarnelli G. Esposito G. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein Neurogastroenterology and Motility 2009 21 11 1209 e112 10.1111/j.1365-2982.2009.01346.x 2-s2.0-70349666893 70349666893 19558426 

    상세보기

40. 40 Talero E. Sánchez-Fidalgo S. de la Lastra C. A. Illanes M. Calvo J. R. Motilva V. Acute and chronic responses associated with adrenomedullin administration in experimental colitis Peptides 2008 29 11 2001 2012 10.1016/j.peptides.2008.07.013 2-s2.0-54049122543 54049122543 18708104 

    상세보기

41. 41 Rosillo M. A. Sánchez-Hidalgo M. Cárdeno A. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats Pharmacological Research 2012 66 3 235 242 10.1016/j.phrs.2012.05.006 2-s2.0-84864276477 84864276477 22677088 

    상세보기

42. 42 Sánchez-Fidalgo S. Cárdeno A. Villegas I. Talero E. de la Lastra C. A. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice European Journal of Pharmacology 2010 633 1-3 78 84 10.1016/j.ejphar.2010.01.025 2-s2.0-77949915935 77949915935 20132809 

    상세보기

43. 43 Barnes P. J. Nuclear factor-kappa B The International Journal of Biochemistry & Cell Biology 1997 29 6 867 870 10.1016/S1357-2725(96)00159-8 2-s2.0-0030797218 9304801 

    상세보기

44. 44 Schreiber S. Nikolaus S. Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease Gut 1998 42 4 477 484 10.1136/gut.42.4.477 0031925362 9616307 

    상세보기

45. 45 Tinker A. C. Wallac A. V. Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases? Current Topics in Medicinal Chemistry 2006 6 2 77 92 10.2174/156802606775270297 2-s2.0-33646169337 33646169337 16454760 

    상세보기

46. 46 Pelletier J. P. Jovanovic D. Fernandes J. C. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase Arthritis and Rheumatism 1998 41 7 1275 1286 10.1002/1529-0131(199807)41:7 3.0.CO;2-T 0031864605 9663486 

    상세보기

47. 47 Lohinai Z. Benedek P. Fehér E. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat British Journal of Pharmacology 1998 123 3 353 360 10.1038/sj.bjp.0701604 2-s2.0-0031963653 0031963653 9504374 

    상세보기

48. 48 Levy B. Valtier M. De Chillou C. Bollaert P. E. Cane D. Mallie J. P. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats Shock 1999 11 2 98 103 10.1097/00024382-199902000-00005 0033073954 10030795 

    상세보기

49. 49 Yoon W. J. Ham Y. M. Yoo B. S. Moon J. Y. Koh J. Hyun C. G. Oenothera laciniata inhibits lipopolysaccharide induced production of nitric oxide, prostaglandin E 2 , and proinflammatory cytokines in RAW264.7 macrophages Journal of Bioscience and Bioengineering 2009 107 4 429 438 10.1016/j.jbiosc.2008.11.018 2-s2.0-62949087077 62949087077 19332304 

    상세보기

50. 50 Ibrahim Abdelwahab S. Syaed Koko W. Mohamed Elhassan Taha M. In vitro and in vivo anti-inflammatory activities of columbin through the inhibition of cycloxygenase-2 and nitric oxide but not the suppression of NF-κB translocation European Journal of Pharmacology 2012 678 1-3 61 70 10.1016/j.ejphar.2011.12.024 2-s2.0-84857050687 84857050687 22227329 

    상세보기

51. 51 Zhang G. Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors Journal of Endotoxin Research 2000 6 6 453 457 10.1177/09680519000060060701 2-s2.0-0034450123 0034450123 11521070 

    상세보기

52. 52 Frankenberger M. Pforte A. Sternsdorf T. Passlick B. Baeuerle P. A. Ziegler-Heitbrock H. W. Constitutive nuclear NF-kappa B in cells of the monocyte lineage The Biochemical Journal 1994 304 87 94 10.1042/bj3040087 0028171328 7998962 

    상세보기

53. 53 Müller J. M. Ziegler-Heitbrock H. W. Baeuerle P. A. Nuclear factor kappa B, a mediator of lipopolysaccharide effects Immunobiology 1993 187 3-5 233 256 10.1016/S0171-2985(11)80342-6 0027264083 8330898 

    상세보기

54. 54 Vanden Berghe W. Plaisance S. Boone E. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor The Journal of Biological Chemistry 1998 273 6 3285 3290 10.1074/jbc.273.6.3285 2-s2.0-0032488837 9452444 

    상세보기

55. 55 Surh Y. J. Chun K. S. Cha H. H. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation Mutation Research 2001 480–481 243 268